Simponi_referral_form

Simponi ARIA® (golimumab) Referral Form
Patient Information
____________________________________________________________________________________________________________________________________________________________________________________
Last Name
____________________________________________________________________________________________________________________________________________________________________________________ Street Address ____________________________________________________________________________________________________________________________________________________________________________________ Phone (daytime)
____________________________________________________________________________________________________________________________________________________________________________________
Primary Insurance Information
Secondary Insurance Information Pharmacy Insurance Card____
__________________________________________________________________________________________________________________________________________________________________________________ Insurance Name ____________________________________________________________________________________________________________________________________________________________________________________ Cardholder Name ____________________________________________________________________________________________________________________________________________________________________________________ Group / Policy Number
Physician Information
___________________________________________________________________________________________________________________________________________________________________________________
Physician Name
___________________________________________________________________________________________________________________________________________________________________________________ Street Address __________________________________________________________________________________________________________________________________________________________________________________ Physician’s DEA Number
Statement of Medical Necessity : PLEASE INCLUDE A COPY OF CHART DOCUMENTATION OF DIAGNOSIS CODES
Other Rheumatoid Arthritis with visceral or systematic involvement ICD-9 Code: 714.2
Date Diagnosed:________________________________________
Medical History :
Patient Weight: _____(Lbs) / _____(Kgs) Height:__________
Tuberculin (PPD) skin test date_____________ Negative Positive If positive: date of last X-Ray:_________________
Hep B Surface Antigen test date____________ Negative Positive
Allergies:___________________________________________________________________________________________________________________________________________________________________________________________________

Prescription Orders:


Simponi ARIA® (golimumab)

Sig: 2mg/kg intravenous (IV). Infuse over 30 minutes. Infuse day 0, 4 weeks then every 8 weeks.
Pre-medications: Acetaminophen 650 mg PO Benadryl 25mg IVP
Promethazine 25mg IVP Solu-Medrol 40 mg IVP Benadryl 25mg PO Other Premeds Needed __________________________________
Standing lab orders: CMP CBC ESR
CRP other:__________________________ every infusion
Refills: _______times or 12 months.

___________________________________________________________________________________________
Physician’s signature

Fax completed form to (214) 887-0436. Contact us directly at: (214) 276-5642.
Or visit us online at www.ntinfusioncenters.com

Source: http://www.ntinfusioncenters.net/images/Simponi_Referral_Form.pdf

Pan_2302 100.106

Review articleDuchenne muscular dystrophy: an old anesthesiaproblem revisitedJASON H AYES M D F RC P C†, F R A N C I S V E Y C K E M A N S M D*A N D B R U N O B I S S O N N E T T E MD FRCPC††The Hospital for Sick Children, Toronto, ON, Canada and*Service d’Anesthe´siologie, Clinique universitaires St Luc, Brussels, BelgiumSummaryPatients with Duchenne and Becker muscular dystrophy suffe

Layout

Monika Schöller-Gyüre No pharmacokinetic interaction between TMC125 Tibotec BVBA Generaal de Wittelaan L11 B3 (etravirine; ETR) and paroxetine in HIV-negative volunteers B2800, Mechelen M Schöller-Gyüre,1 TN Kakuda,2 S Bollen,1 G De Smedt,1 B Woodfall,1 M Peeters,1 K Vandermeulen,1 RM Hoetelmans1 mscholle@tibbe.jnj.com Tibotec BVBA, Mechelen, Belgium; 2Tibotec Inc., Ya

© 2010-2018 PDF pharmacy articles